Axsome Therapeutics (AXSM)
(Real Time Quote from BATS)
$82.00 USD
+1.79 (2.23%)
Updated Jul 5, 2024 03:51 PM ET
After-Market: $82.15 +0.15 (0.18%) 4:16 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -1.32 |
EPS Last Quarter | -1.09 |
Last EPS Surprise | 9.17% |
ABR | 1.19 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.93 |
Next Year | -0.23 |
EPS (TTM) | -4.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 83.63M | 94.55M | 361.71M | 636.39M |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 87.20M | 101.40M | 384.70M | 738.14M |
Low Estimate | 80.32M | 88.00M | 347.10M | 467.71M |
Year ago Sales | 46.70M | 57.79M | 270.60M | 361.71M |
Year over Year Growth Est. | 79.07% | 63.62% | 33.67% | 75.94% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.32 | -1.12 | -4.93 | -0.23 |
# of Estimates | 8 | 7 | 10 | 10 |
Most Recent Consensus | -1.43 | -1.24 | -5.27 | -3.39 |
High Estimate | -0.91 | -0.75 | -3.62 | 3.53 |
Low Estimate | -1.67 | -1.35 | -6.22 | -3.91 |
Year ago EPS | -1.00 | -1.32 | -2.67 | -4.93 |
Year over Year Growth Est. | -32.00% | 15.15% | -84.64% | 95.38% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 7 | 7 | 9 | 7 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.32 | -1.12 | -4.93 | -0.23 |
7 Days Ago | -1.32 | -1.12 | -4.93 | -0.23 |
30 Days Ago | -1.32 | -1.12 | -4.93 | -0.23 |
60 Days Ago | -1.07 | -0.86 | -3.86 | 0.68 |
90 Days Ago | -1.10 | -0.89 | -3.89 | 0.53 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.32 | -1.12 | -4.93 | -0.23 |
Zacks Consensus Estimate | -1.32 | -1.12 | -4.93 | -0.23 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.09 | -0.73 | -1.32 | -1.00 | NA |
Estimate | -1.20 | -1.21 | -1.24 | -1.24 | NA |
Difference | 0.11 | 0.48 | -0.08 | 0.24 | 0.19 |
Surprise | 9.17% | 39.67% | -6.45% | 19.35% | 15.44% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more